Investment Analysts’ downgrades for Thursday, April 17th:
Amgen (NASDAQ:AMGN) was downgraded by analysts at StockNews.com from a strong-buy rating to a buy rating.
BioMarin Pharmaceutical (NASDAQ:BMRN) was downgraded by analysts at StockNews.com from a strong-buy rating to a buy rating.
Cellectis (NASDAQ:CLLS) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.
Coty (NYSE:COTY) was downgraded by analysts at Raymond James from an outperform rating to a market perform rating.
Calavo Growers (NASDAQ:CVGW) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.
Comfort Systems USA (NYSE:FIX) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.
Global Payments (NYSE:GPN) was downgraded by analysts at Keefe, Bruyette & Woods from an outperform rating to a market perform rating. They currently have $78.00 target price on the stock, down from their previous target price of $135.00.
Henry Schein (NASDAQ:HSIC) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.
21529 (ISC.V) (CVE:ISC) was downgraded by analysts at CIBC from an outperform rating to a neutral rating. CIBC currently has C$30.00 price target on the stock, down from their previous price target of C$32.00.
Obsidian Energy (TSE:OBE) was downgraded by analysts at Royal Bank of Canada from an outperform rating to a sector perform rating. The firm currently has C$10.00 target price on the stock, down from their previous target price of C$12.00.
Constellation Brands (NYSE:STZ) was downgraded by analysts at StockNews.com from a hold rating to a sell rating.
Suncor Energy (NYSE:SU) (TSE:SU) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.
U.S. Physical Therapy (NYSE:USPH) was downgraded by analysts at StockNews.com from a hold rating to a sell rating.
Walmart (NYSE:WMT) was downgraded by analysts at StockNews.com from a buy rating to a hold rating.
Receive News & Ratings for Amgen Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amgen Inc and related companies with MarketBeat.com's FREE daily email newsletter.